Wise Group plc (NASDAQ: WSE) faces a September 29 lead plaintiff deadline in a securities class action alleging the fintech understated anti-money laundering risks before its Nasdaq debut. The complaint names CEO Kristo Käärmann and CFO Emmanuel Thomassin as individual defendants. Shares fell 16.05 percent across June 1-3 sessions and another 6.2 percent on July 24.
Wise Group faces a September 29 lead plaintiff deadline in a securities class action over alleged anti-money laundering failures tied to its Nasdaq debut.
"Corporate officers have a duty to ensure their companies' public statements are accurate and complete," Joseph E. Levi, founding partner at Levi & Korsinsky, said. "The complaint alleges that risk disclosures describing anti-money laundering compliance failures in hypothetical terms were signed while a longstanding deficiency was allegedly already present."
The class action covers investors who purchased Wise securities between May 11 and July 23, 2026. The complaint names CEO Kristo Käärmann and CFO Emmanuel Thomassin as individual defendants under Section 20(a) of the Securities Exchange Act of 1934, alongside primary claims under Section 10(b) and Rule 10b-5. The Section 20(a) framework holds that officers who controlled the company may be personally answerable for alleged violations of the entity they controlled. Wise's U.S.-listed shares fell $0.67, or 5.24 percent, to $12.10 on June 1 after Reuters reported that Brussels prosecutors were investigating the company's European entity over more than half a billion euros in suspicious transactions. Shares dropped a further $0.75, or 6.2 percent, to $11.33 on July 24 after the Office of the Comptroller of the Currency denied Wise's application for a national trust bank license, citing deficiencies in its anti-money laundering and counter-terrorism financing programs.
The lawsuit alleges Wise materially understated regulatory risks to ensure a successful Nasdaq debut on May 11. The complaint, filed in the U.S. District Court for the Southern District of New York, asserts that statements about the company's business and prospects were materially false and misleading throughout the class period.
Multiple firms — including Glancy Prongay Wolke & Rotter, Bronstein Gewirtz & Grossman, Rosen Law Firm, and Faruqi & Faruqi — are soliciting affected investors. The stock declined $2.05, or 16.05 percent, across the June 1-3 trading sessions, closing at $10.72, before the additional drop on July 24. The Brussels investigation, which began last year and is nearing completion, concerns potential money laundering offenses with alleged links to fraud, corruption, and drug trafficking.
The September 29 deadline applies to investors seeking appointment as lead plaintiff, the representative party directing the litigation. Investors who purchased during the class period may be eligible for recovery regardless of whether they still hold the shares, and participation carries no upfront cost under contingency fee arrangements. The OCC's rejection letter stated that Wise's application presented significant supervisory and compliance concerns.
The outcome of the case could set a precedent for how fintech companies disclose regulatory compliance risks ahead of U.S. listings. Investors will watch for the court's lead plaintiff appointment and any subsequent settlement or dismissal proceedings. The case also highlights the regulatory scrutiny facing cross-border fintech platforms expanding into the U.S. banking system.
This article is for informational purposes only and does not constitute investment advice.
